HG Breakthrough: Six New Genetic Culprits Identified

Scientists have uncovered six novel genetic links associated with hyperemesis gravidarum (HG), a severe form of morning sickness. This groundbreaking research, conducted by a team from the Keck School of Medicine of USC and international collaborators, analyzed genetic data from nearly 500,000 women. The study confirmed the gene GDF15 as a primary factor in HG and identified nine additional genes, with six being newly tied to the condition.

The findings are significant because they were derived from a diverse population, increasing the confidence that these genetic links apply broadly. The identified genes are involved in crucial biological processes such as appetite regulation, nausea signaling, and metabolism. Researchers noted a potential overlap between HG-linked genes and other pregnancy complications, including preeclampsia and lower birth weight.

These genetic insights pave the way for developing new, targeted therapies for HG, which currently has limited treatment options. A clinical trial is set to test metformin, a diabetes medication, to see if it can reduce HG severity by potentially lowering sensitivity to GDF15 before pregnancy.